Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced / Metastatic Solid Tumor”

2,065 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,065 results

Testing effectiveness (Phase 2)Study completedNCT04645069
What this trial is testing

ADG126, ADG126 in Combination With Anti PD1 Antibody, and ADG126 in Combination With ADG106 in Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced/Metastatic Solid Tumors
Adagene Inc 58
Early research (Phase 1)Not Yet RecruitingNCT05474859
What this trial is testing

Subjects With Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
Metastatic Solid TumorAdvanced Solid Tumor
Xenthera, Inc. 30
Early research (Phase 1)Study completedNCT00516724
What this trial is testing

Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel

Who this might be right for
Triple Negative Metastatic Breast CancerAdvanced Ovarian CancerCarboplatin+1 more
AstraZeneca 189
Early research (Phase 1)Study completedNCT05735366
What this trial is testing

SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor
Chugai Pharmaceutical 22
Early research (Phase 1)Study completedNCT04275960
What this trial is testing

Study in Healthy Adult Male Participants to Gather Information How the Human Body Absorbs, Distributes and Excretes the Study Drug Selitrectinib Including the Effect of the Interaction of Food With the Study Drug on the Human Body

Who this might be right for
Solid Tumors Harboring NTRK Fusion
Bayer 24
Early research (Phase 1)Study completedNCT05990920
What this trial is testing

Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy

Who this might be right for
Pathologically Confirmed Cancer Refractory to Conventional TherapyRefractory CancerMetastatic Cancer+5 more
NKGen Biotech, Inc. 6
Early research (Phase 1)Ended earlyNCT03809624
What this trial is testing

Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer

Who this might be right for
Metastatic Solid TumorsNon-small Cell Lung CancerMelanoma+6 more
Inhibrx Biosciences, Inc 160
Early research (Phase 1)Ended earlyNCT02668770
What this trial is testing

Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies

Who this might be right for
Advanced CancersMelanoma
M.D. Anderson Cancer Center 28
Early research (Phase 1)Ended earlyNCT03739138
What this trial is testing

Intratumoral/Intralesional Administration of MK-4621/JetPEI™ With or Without Pembrolizumab in Participants With Advanced/Metastatic or Recurrent Solid Tumors (MK-4621-002)

Who this might be right for
Advanced Solid Tumors
Merck Sharp & Dohme LLC 30
Not applicableStudy completedNCT01855477
What this trial is testing

CPCT-02 Biopsy Protocol

Who this might be right for
Solid TumorsMetastatic Disease
Foundation CPCT 6,927
Early research (Phase 1)Looking for participantsNCT07030712
What this trial is testing

A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)

Who this might be right for
Metastatic Neoplasm
Merck Sharp & Dohme LLC 67
Early research (Phase 1)Active Not RecruitingNCT05853367
What this trial is testing

Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001)

Who this might be right for
Metastatic Solid TumorsAdvanced Solid Tumors
Merck Sharp & Dohme LLC 95
Early research (Phase 1)Study completedNCT00980239
What this trial is testing

HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver

Who this might be right for
Liver CancerAdvanced Cancer
M.D. Anderson Cancer Center 115
Testing effectiveness (Phase 2)Ended earlyNCT02100007
What this trial is testing

ME-344 Given in Combination With Hycamtin® in Patients With Solid Tumors

Who this might be right for
Solid Tumors
MEI Pharma, Inc. 46
Early research (Phase 1)Study completedNCT04050709
What this trial is testing

QUILT-3.064: PD-L1 t-haNK In Subjects With Locally Advanced Or Metastatic Solid Cancers

Who this might be right for
Locally Advanced Solid TumorMetastatic CancerSolid Tumor
ImmunityBio, Inc. 16
Early research (Phase 1)Ended earlyNCT02620839
What this trial is testing

Phase Ib Study of Alpelisib With Cisplatin in Patients With HPV+ Solid Tumor Malignancies

Who this might be right for
Solid Tumors
Pamela Munster 28
Early research (Phase 1)Study completedNCT01011972
What this trial is testing

Intravenous XMT-1107 in Patients With Advanced Solid Tumors

Who this might be right for
Neoplasm Metastasis
Mersana Therapeutics 52
Early research (Phase 1)Looking for participantsNCT06307795
What this trial is testing

Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
Avistone Biotechnology Co., Ltd. 63
Early research (Phase 1)Looking for participantsNCT06010875
What this trial is testing

A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

Who this might be right for
Renal Cell CarcinomaOvarian CancerCervix Cancer+2 more
Chongqing Precision Biotech Co., Ltd 48
Early research (Phase 1)Study completedNCT03027128
What this trial is testing

QUILT-3.028: Study of haNK™ for Infusion in Subjects With Metastatic or Locally Advanced Solid Tumors

Who this might be right for
Solid Tumor
ImmunityBio, Inc. 6
Next Page